| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Adipocytokine signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 2 | African trypanosomiasis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 3 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 4 | Allograft rejection 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 5 | Alzheimer disease 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 6 | Amoebiasis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 7 | Amphetamine addiction 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 8 | Amyotrophic lateral sclerosis (ALS) 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 9 | Antifolate resistance 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 10 | Antigen processing and presentation 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 11 | Apoptosis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 12 | Asthma 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 13 | Axon guidance 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 14 | B cell receptor signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 15 | C-type lectin receptor signaling pathway 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 16 | Calcium signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 17 | Cellular senescence 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 18 | cGMP-PKG signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 19 | Chagas disease (American trypanosomiasis) 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 20 | Cytokine-cytokine receptor interaction 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 21 | Dilated cardiomyopathy (DCM) 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 22 | Dopaminergic synapse 3 genes, 1 drug (DrugBank), 30 diseases shown |
[3] PPP3CA, PPP3CB, PPP3CC |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 23 | Epstein-Barr virus infection 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 24 | Fc epsilon RI signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 25 | Fluid shear stress and atherosclerosis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 26 | Glucagon signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 27 | Glutamatergic synapse 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 28 | Graft-versus-host disease 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 29 | Hematopoietic cell lineage 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 30 | Hepatitis B 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 31 | Hepatitis C 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 32 | Herpes simplex virus 1 infection 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 33 | Human cytomegalovirus infection 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 34 | Human immunodeficiency virus 1 infection 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 35 | Human papillomavirus infection 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 36 | Human T-cell leukemia virus 1 infection 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 37 | Hypertrophic cardiomyopathy (HCM) 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 38 | IL-17 signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 39 | Inflammatory bowel disease (IBD) 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 40 | Influenza A 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 41 | Insulin resistance 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 42 | Kaposi sarcoma-associated herpesvirus infection 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 43 | Legionellosis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 44 | Leishmaniasis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 45 | Long-term potentiation 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 46 | Malaria 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 47 | MAPK signaling pathway 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 48 | mTOR signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 49 | Natural killer cell mediated cytotoxicity 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 50 | Necroptosis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 51 | NF-kappa B signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 52 | NOD-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 53 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 54 | Oocyte meiosis 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 55 | Osteoclast differentiation 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 56 | Oxytocin signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 57 | Pathogenic Escherichia coli infection 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 58 | PD-L1 expression and PD-1 checkpoint pathway in cancer 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 59 | Pertussis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 60 | Proteoglycans in cancer 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 61 | Renin secretion 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 62 | Rheumatoid arthritis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 63 | RIG-I-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 64 | Shigellosis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 65 | Sphingolipid signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 66 | Systemic lupus erythematosus 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 67 | T cell receptor signaling pathway 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 68 | TGF-beta signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 69 | Th1 and Th2 cell differentiation 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 70 | Th17 cell differentiation 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 71 | TNF signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 72 | Toll-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 73 | Toxoplasmosis 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 74 | Tuberculosis 6 genes, 2 drugs (DrugBank), 38 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 75 | Type I diabetes mellitus 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 76 | Type II diabetes mellitus 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 77 | VEGF signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 78 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| 79 | Wnt signaling pathway 5 genes, 1 drug (DrugBank), 30 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 80 | Yersinia infection 1 gene, 1 drug (DrugBank), 15 diseases shown |
[1] TNF |
D02597 |
Adalimumab |
[15] 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |